4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept

Details 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept

1998-02-17

1999-11-23

Morris, Patricia L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

5483047, 5483064, A61K 31415, C07D40912, C07D40512, C07D23526

Patent

active

059901446

ABSTRACT:
Disclosed are compounds of the formula ##STR1## wherein: R.sup.1 is hydrogen or C.sub.1 -C.sub.6 alkyl;

REFERENCES:
patent: 4140789 (1979-02-01), Jaeggi
patent: 5750556 (1998-05-01), Mewshaw et al.
patent: 5760070 (1998-06-01), Mewshaw et al.
Joseph Weinstock et al., J. Med. Chem., 30, 1166-1176 (1987).
Juan C. Jaen et al., J. Med. Chem., 31, 1621-1625 (1988).
Staehelin et al., J. Biological Chemistry 258 (6) 3496-3502,1983.

Affiliated with

Also associated with

Rating

4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autorecept will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1222399